Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245

1.

Safety of robotic assisted laparoscopic recurrent paraesophageal hernia repair: insights from a large single institution experience.

Sowards KJ, Holton NF, Elliott EG, Hall J, Bajwa KS, Snyder BE, Wilson TD, Mehta SS, Walker PA, Chandwani KD, Klein CL, Rivera AR, Wilson EB, Shah SK, Felinski MM.

Surg Endosc. 2019 Dec 6. doi: 10.1007/s00464-019-07291-y. [Epub ahead of print]

PMID:
31811451
2.

Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.

Close HJ, Stead LF, Nsengimana J, Reilly KA, Droop A, Wurdak H, Mathew RK, Corns R, Newton-Bishop J, Melcher AA, Short SC, Cook GP, Wilson EB.

Clin Exp Immunol. 2019 Nov 30. doi: 10.1111/cei.13403. [Epub ahead of print]

PMID:
31784984
3.

TEMPORARY REMOVAL: ABE/ASGE position statement on training and privileges for primary endoscopic bariatric therapies.

Kumar N, Dayyeh BA, Dunkin BJ, Neto MG, Gomez V, Jonnalagadda S, Kumbhari V, Larsen MC, Pannala R, Ryou MK, Sullivan SA, Wilson EB, Thompson CC.

Gastrointest Endosc. 2019 Sep 23. pii: S0016-5107(19)32065-6. doi: 10.1016/j.gie.2019.07.017. [Epub ahead of print]

PMID:
31558279
4.

Correction to: Trocar site closure with a novel anchor-based (neoClose®) system versus standard suture closure: a prospective randomized controlled trial.

Iranmanesh P, Rivera AR, Bajwa KS, Alibhai M, Snyder BE, Wilson TD, Felinski MM, Mehta SS, Chandwani KD, Klein CL, Walker PA, Shah SK, Wilson EB.

Surg Endosc. 2019 Sep 4. doi: 10.1007/s00464-019-07111-3. [Epub ahead of print]

PMID:
31485931
5.

Endoscopic sleeve gastroplasty is safe and effective: pitfalls of a flawed systematic review.

Abu Dayyeh BK, Neto MG, Lopez-Nava G, Sharaiha RZ, Kumbhari V, Wilson EB.

Surg Obes Relat Dis. 2019 Aug;15(8):1423-1424. doi: 10.1016/j.soard.2019.05.011. Epub 2019 May 21. No abstract available.

PMID:
31229395
6.

Trocar site closure with a novel anchor-based (neoClose®) system versus standard suture closure: a prospective randomized controlled trial.

Iranmanesh P, Rivera AR, Bajwa KS, Alibhai M, Snyder BE, Wilson TD, Felinski MM, Mehta SS, Chandwani KD, Klein CL, Walker PA, Shah SK, Wilson EB.

Surg Endosc. 2019 Jun 10. doi: 10.1007/s00464-019-06891-y. [Epub ahead of print] Erratum in: Surg Endosc. 2019 Sep 4;:.

PMID:
31183797
7.

Non-radiometric Cell-free Assay to Measure the Effect of Molecular Chaperones on AMP-activated Kinase Activity.

Wilson EB, Rubel CE, Schisler JC.

Bio Protoc. 2019 Apr 20;9(8). pii: e3218. doi: 10.21769/BioProtoc.3218.

8.

Multicenter review of robotic versus laparoscopic ventral hernia repair: is there a role for robotics?

Walker PA, May AC, Mo J, Cherla DV, Santillan MR, Kim S, Ryan H, Shah SK, Wilson EB, Tsuda S.

Surg Endosc. 2018 Apr;32(4):1901-1905. doi: 10.1007/s00464-017-5882-5. Epub 2018 Feb 6.

PMID:
29411133
9.

Transoral outlet reduction with full thickness endoscopic suturing for weight regain after gastric bypass: a large multicenter international experience and meta-analysis.

Vargas EJ, Bazerbachi F, Rizk M, Rustagi T, Acosta A, Wilson EB, Wilson T, Neto MG, Zundel N, Mundi MS, Collazo-Clavell ML, Meera S, Abu-Lebdeh HS, Lorentz PA, Grothe KB, Clark MM, Kellogg TA, McKenzie TJ, Kendrick ML, Topazian MD, Gostout CJ, Abu Dayyeh BK.

Surg Endosc. 2018 Jan;32(1):252-259. doi: 10.1007/s00464-017-5671-1. Epub 2017 Jun 29.

PMID:
28664438
10.

Evaluation of a Low-Fidelity Surgical Simulator for Large Loop Excision of the Transformation Zone (LLETZ).

Wilson EB, Beckmann MM, Hewett DG, Jolly BC, Janssens S.

Simul Healthc. 2017 Oct;12(5):304-307. doi: 10.1097/SIH.0000000000000242.

PMID:
28609316
11.

The Influence of the Orbera Intragastric Balloon Filling Volumes on Weight Loss, Tolerability, and Adverse Events: a Systematic Review and Meta-Analysis.

Kumar N, Bazerbachi F, Rustagi T, McCarty TR, Thompson CC, Galvao Neto MP, Zundel N, Wilson EB, Gostout CJ, Abu Dayyeh BK.

Obes Surg. 2017 Sep;27(9):2272-2278. doi: 10.1007/s11695-017-2636-3. Review.

PMID:
28285471
12.

Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence.

Cunningham CR, Champhekar A, Tullius MV, Dillon BJ, Zhen A, de la Fuente JR, Herskovitz J, Elsaesser H, Snell LM, Wilson EB, de la Torre JC, Kitchen SG, Horwitz MA, Bensinger SJ, Smale ST, Brooks DG.

PLoS Pathog. 2016 Jan 25;12(1):e1005356. doi: 10.1371/journal.ppat.1005356. eCollection 2016 Jan.

13.

A review of the role of robotics in bariatric surgery.

Alibhai MH, Shah SK, Walker PA, Wilson EB.

J Surg Oncol. 2015 Sep;112(3):279-83. doi: 10.1002/jso.23913. Epub 2015 May 7. Review.

PMID:
25953149
14.

The economy of motion of the totally robotic gastric bypass: technique, learning curve, and outcomes of a fellowship-trained, robotic bariatric surgeon.

Starnes CC, Gochnour DC, Hall B, Wilson EB, Snyder BE.

J Laparoendosc Adv Surg Tech A. 2015 May;25(5):411-8. doi: 10.1089/lap.2014.0501. Epub 2015 Apr 8.

PMID:
25853837
15.

Training paramedics in focussed echo in life support.

Booth KL, Reed MJ, Brady S, Cranfield KR, Kishen R, Letham K, McAlpine G, Murray DB, Wilson EB, Wilson M, Short S, Clegg GR.

Eur J Emerg Med. 2015 Dec;22(6):430-5. doi: 10.1097/MEJ.0000000000000246.

PMID:
25647037
16.

Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT.

Holmes TD, Wilson EB, Black EV, Benest AV, Vaz C, Tan B, Tanavde VM, Cook GP.

Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):E5688-96. doi: 10.1073/pnas.1411072112. Epub 2014 Dec 15.

17.

Controlled infection with a therapeutic virus defines the activation kinetics of human natural killer cells in vivo.

El-Sherbiny YM, Holmes TD, Wetherill LF, Black EV, Wilson EB, Phillips SL, Scott GB, Adair RA, Dave R, Scott KJ, Morgan RS, Coffey M, Toogood GJ, Melcher AA, Cook GP.

Clin Exp Immunol. 2015 Apr;180(1):98-107. doi: 10.1111/cei.12562.

18.

Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial.

Hunter JG, Kahrilas PJ, Bell RC, Wilson EB, Trad KS, Dolan JP, Perry KA, Oelschlager BK, Soper NJ, Snyder BE, Burch MA, Melvin WS, Reavis KM, Turgeon DG, Hungness ES, Diggs BS.

Gastroenterology. 2015 Feb;148(2):324-333.e5. doi: 10.1053/j.gastro.2014.10.009. Epub 2014 Oct 13.

19.

Completely intracorporeal robotic-assisted laparoscopic augmentation enterocystoplasty with continent catheterizable channel.

Flum AS, Zhao LC, Kielb SJ, Wilson EB, Shu T, Hairston JC.

Urology. 2014 Dec;84(6):1314-8. doi: 10.1016/j.urology.2014.09.009.

PMID:
25432822
20.

Type I interferon suppresses de novo virus-specific CD4 Th1 immunity during an established persistent viral infection.

Osokine I, Snell LM, Cunningham CR, Yamada DH, Wilson EB, Elsaesser HJ, de la Torre JC, Brooks D.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):7409-14. doi: 10.1073/pnas.1401662111. Epub 2014 May 5.

21.

The effects of transoral incisionless fundoplication on chronic GERD patients: 12-month prospective multicenter experience.

Wilson EB, Barnes WE, Mavrelis PG, Carter BJ, Bell RC, Sewell RW, Ihde GM, Dargis D, Hoddinott KM, Shughoury AB, Gill BD, Fox MA, Turgeon DG, Freeman KD, Gunsberger T, Hausmann MG, Leblanc KA, Deljkich E, Trad KS.

Surg Laparosc Endosc Percutan Tech. 2014 Feb;24(1):36-46. doi: 10.1097/SLE.0b013e3182a2b05c.

PMID:
24487156
22.

Correlation between intraocular pressure and body mass index in the seated and supine positions.

Geloneck MM, Crowell EL, Wilson EB, Synder BE, Chuang AZ, Baker LA, Bell NP, Feldman RM.

J Glaucoma. 2015 Feb;24(2):130-4. doi: 10.1097/01.ijg.0000435775.05032.87.

PMID:
24247996
23.

Decoding the complexity of type I interferon to treat persistent viral infections.

Wilson EB, Brooks DG.

Trends Microbiol. 2013 Dec;21(12):634-40. doi: 10.1016/j.tim.2013.10.003. Epub 2013 Nov 8. Review.

24.

Interfering with type I interferon: a novel approach to purge persistent viral infection.

Wilson EB, Brooks DG.

Cell Cycle. 2013 Sep 15;12(18):2919-20. doi: 10.4161/cc.26175. Epub 2013 Aug 23. No abstract available.

25.

The evolution of robotic bariatric surgery.

Wilson EB, Sudan R.

World J Surg. 2013 Dec;37(12):2756-60. doi: 10.1007/s00268-013-2125-3. Review.

PMID:
23778837
26.

Clinical outcomes of the Realize Adjustable Gastric Band-C at 2 years in a United States population.

Cunneen SA, Brathwaite CE, Joyce C, Gersin K, Kim K, Schram JL, Wilson EB, Schwiers M, Gutierrez M.

Surg Obes Relat Dis. 2013 Nov-Dec;9(6):885-93. doi: 10.1016/j.soard.2013.02.009. Epub 2013 Mar 14.

PMID:
23642493
27.

Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Wilson EB, Yamada DH, Elsaesser H, Herskovitz J, Deng J, Cheng G, Aronow BJ, Karp CL, Brooks DG.

Science. 2013 Apr 12;340(6129):202-7. doi: 10.1126/science.1235208.

28.

Sterol regulatory element-binding proteins are essential for the metabolic programming of effector T cells and adaptive immunity.

Kidani Y, Elsaesser H, Hock MB, Vergnes L, Williams KJ, Argus JP, Marbois BN, Komisopoulou E, Wilson EB, Osborne TF, Graeber TG, Reue K, Brooks DG, Bensinger SJ.

Nat Immunol. 2013 May;14(5):489-99. doi: 10.1038/ni.2570. Epub 2013 Apr 7.

29.

Inflammation makes T cells sensitive.

Wilson EB, Brooks DG.

Immunity. 2013 Jan 24;38(1):5-7. doi: 10.1016/j.immuni.2013.01.001.

30.

Stent induced gastric wall erosion and endoscopic retrieval of nonadjustable gastric band: a new technique.

Wilson TD, Miller N, Brown N, Snyder BE, Wilson EB.

Surg Endosc. 2013 May;27(5):1617-21. doi: 10.1007/s00464-012-2638-0. Epub 2012 Dec 12.

PMID:
23233012
31.

Splenic red pulp macrophages produce type I interferons as early sentinels of malaria infection but are dispensable for control.

Kim CC, Nelson CS, Wilson EB, Hou B, DeFranco AL, DeRisi JL.

PLoS One. 2012;7(10):e48126. doi: 10.1371/journal.pone.0048126. Epub 2012 Oct 29.

32.

Emergence of distinct multiarmed immunoregulatory antigen-presenting cells during persistent viral infection.

Wilson EB, Kidani Y, Elsaesser H, Barnard J, Raff L, Karp CL, Bensinger S, Brooks DG.

Cell Host Microbe. 2012 May 17;11(5):481-91. doi: 10.1016/j.chom.2012.03.009.

33.

Optimization of propafenone analogues as antimalarial leads.

Lowes DJ, Guiguemde WA, Connelly MC, Zhu F, Sigal MS, Clark JA, Lemoff AS, Derisi JL, Wilson EB, Guy RK.

J Med Chem. 2011 Nov 10;54(21):7477-85. doi: 10.1021/jm2005546. Epub 2011 Oct 10.

34.

Synthesis and evaluation of 7-substituted 4-aminoquinoline analogues for antimalarial activity.

Hwang JY, Kawasuji T, Lowes DJ, Clark JA, Connelly MC, Zhu F, Guiguemde WA, Sigal MS, Wilson EB, Derisi JL, Guy RK.

J Med Chem. 2011 Oct 27;54(20):7084-93. doi: 10.1021/jm200636z. Epub 2011 Sep 26.

35.

Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.

Wilson EB, El-Jawhari JJ, Neilson AL, Hall GD, Melcher AA, Meade JL, Cook GP.

PLoS One. 2011;6(9):e22842. doi: 10.1371/journal.pone.0022842. Epub 2011 Sep 6.

36.

Clinical outcomes of the REALIZE adjustable gastric band-C at one year in a U.S. population.

Cunneen SA, Brathwaite CE, Joyce C, Gersin K, Kim K, Schram JL, Wilson EB, Rodriguez CE, Gutierrez M.

Surg Obes Relat Dis. 2012 May-Jun;8(3):288-95. doi: 10.1016/j.soard.2011.05.004. Epub 2011 May 20.

PMID:
21775219
37.

Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells.

Fahey LM, Wilson EB, Elsaesser H, Fistonich CD, McGavern DB, Brooks DG.

J Exp Med. 2011 May 9;208(5):987-99. doi: 10.1084/jem.20101773. Epub 2011 May 2.

38.

Type I interferon supports primary CD8+ T-cell responses to peptide-pulsed dendritic cells in the absence of CD4+ T-cell help.

Ontiveros F, Wilson EB, Livingstone AM.

Immunology. 2011 Apr;132(4):549-58. doi: 10.1111/j.1365-2567.2010.03400.x. Epub 2011 Jan 24.

39.

Translating insights from persistent LCMV infection into anti-HIV immunity.

Wilson EB, Brooks DG.

Immunol Res. 2010 Dec;48(1-3):3-13. doi: 10.1007/s12026-010-8162-1. Review.

40.

Identification of the BCL2/adenovirus E1B-19K protein-interacting protein 2 (BNIP-2) as a granzyme B target during human natural killer cell-mediated killing.

Scott GB, Bowles PA, Wilson EB, Meade JL, Low BC, Davison A, Blair GE, Cook GP.

Biochem J. 2010 Nov 1;431(3):423-31. doi: 10.1042/BJ20091073.

PMID:
20704564
41.

The role of IL-10 in regulating immunity to persistent viral infections.

Wilson EB, Brooks DG.

Curr Top Microbiol Immunol. 2011;350:39-65. doi: 10.1007/82_2010_96. Review.

42.

Epidemiological review and proposed management of 'scaphoid' injury in children.

Wilson EB, Beattie TF, Wilkinson AG.

Eur J Emerg Med. 2011 Feb;18(1):57-61. doi: 10.1097/MEJ.0b013e32833c9312.

PMID:
20585258
43.

Progressive regression of left ventricular hypertrophy two years after bariatric surgery.

Algahim MF, Lux TR, Leichman JG, Boyer AF, Miller CC 3rd, Laing ST, Wilson EB, Scarborough T, Yu S, Snyder B, Wolin-Riklin C, Kyle UG, Taegtmeyer H.

Am J Med. 2010 Jun;123(6):549-55. doi: 10.1016/j.amjmed.2009.11.020. Erratum in: Am J Med. 2010 Oct;123(10):e13.

44.

Chemical genetics of Plasmodium falciparum.

Guiguemde WA, Shelat AA, Bouck D, Duffy S, Crowther GJ, Davis PH, Smithson DC, Connelly M, Clark J, Zhu F, Jiménez-Díaz MB, Martinez MS, Wilson EB, Tripathi AK, Gut J, Sharlow ER, Bathurst I, El Mazouni F, Fowble JW, Forquer I, McGinley PL, Castro S, Angulo-Barturen I, Ferrer S, Rosenthal PJ, Derisi JL, Sullivan DJ, Lazo JS, Roos DS, Riscoe MK, Phillips MA, Rathod PK, Van Voorhis WC, Avery VM, Guy RK.

Nature. 2010 May 20;465(7296):311-5. doi: 10.1038/nature09099.

45.

Improved methods for magnetic purification of malaria parasites and haemozoin.

Kim CC, Wilson EB, DeRisi JL.

Malar J. 2010 Jan 14;9:17. doi: 10.1186/1475-2875-9-17.

46.

Robotic-assisted Roux-en-Y Gastric bypass: minimizing morbidity and mortality.

Snyder BE, Wilson T, Leong BY, Klein C, Wilson EB.

Obes Surg. 2010 Mar;20(3):265-70. doi: 10.1007/s11695-009-0012-7. Epub 2009 Nov 3.

PMID:
19885708
47.

The evolution of robotic general surgery.

Wilson EB.

Scand J Surg. 2009;98(2):125-9. Review.

PMID:
19799050
48.

Proteolytic activation of the cytotoxic phenotype during human NK cell development.

Meade JL, Wilson EB, Holmes TD, de Wynter EA, Brett P, Straszynski L, Ballard PA, Trapani JA, McDermott MF, Cook GP.

J Immunol. 2009 Jul 15;183(2):803-13. doi: 10.4049/jimmunol.0713829. Epub 2009 Jul 1.

49.

Endoscopic management of eroded prosthesis in vertical banded gastroplasty patients.

Karmali S, Snyder B, Wilson EB, Timberlake MD, Sherman V.

Surg Endosc. 2010 Jan;24(1):98-102. doi: 10.1007/s00464-009-0532-1. Epub 2009 Jun 11.

PMID:
19517187
50.

Unravelling the mechanisms of help for CD8+ T cell responses.

Livingstone AM, Wilson EB, Ontiveros F, Wang JC.

Immunol Res. 2009 Dec;45(2-3):209-17. doi: 10.1007/s12026-009-8102-0. Epub 2009 Feb 18. Review.

PMID:
19224140

Supplemental Content

Loading ...
Support Center